광고환영

광고문의환영
Showing posts with the label biotechShow all
South Korean biotech AprilBio raises about $103 million in targeted stock sale to fund R&D
Early Leukemia Trial Puts Spotlight on a Korea-Linked Drug Candidate — and on the Promise and Limits of Cancer Research Headlines
As Yuhan Corp. Nears 100 Years, South Korea’s Oldest Pharmaceutical Story Turns Toward a Global Future
South Korea’s 43rd Homegrown Drug Marks a Turning Point for a Fast-Maturing Biotech Industry
A New Korean Cancer Analysis Tool Aims to Predict Immunotherapy Success Before Treatment Begins
South Korea Clears Its First Regenerative Medicine Treatment Plan, Opening a New Chapter for Patients With Rare Diseases